{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:27:27Z","timestamp":1791300447702,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006109","name":"VEGA","doi-asserted-by":"crossref","award":["1\/0858\/11"],"award-info":[{"award-number":["1\/0858\/11"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s12325-015-0253-x","type":"journal-article","created":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:37:23Z","timestamp":1446424643000},"page":"962-970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effect of Ivabradine on Endothelial Function in Patients with Stable Angina Pectoris: Assessment with the Endo-PAT 2000 Device"],"prefix":"10.1007","volume":"32","author":[{"given":"Lucia","family":"Jedlickova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Merkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Jackova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Janicko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fedacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozena","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chmelarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Majernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,2]]},"reference":[{"issue":"1","key":"253_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1476-5381.1994.tb13025.x","volume":"112","author":"C Thollon","year":"1994","unstructured":"Thollon C, Cambarrat C, Vian J, et al. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994;112(1):37\u201342.","journal-title":"Br J Pharmacol"},{"issue":"38","key":"253_CR2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, et al. ESC Guidelines on the management of stable coronary artery disease. The Task Force on the Management of Stable Coronary Artery Disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949\u20133003.","journal-title":"Eur Heart J"},{"issue":"23","key":"253_CR3","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","volume":"26","author":"JC Tardif","year":"2005","unstructured":"Tardif JC, Ford I, Tendera M, et al. Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J. 2005;26(23):2529\u201336.","journal-title":"Eur Heart J"},{"issue":"5","key":"253_CR4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/eurheartj\/ehn571","volume":"30","author":"JC Tardif","year":"2009","unstructured":"Tardif JC, Ponikowski P, Kahan T, et al. Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a\u00a04-month, randomized, placebo-controlled trial. Eur Heart J. 2009;30(5):540\u20138.","journal-title":"Eur Heart J"},{"issue":"9641","key":"253_CR5","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","volume":"372","author":"K Fox","year":"2008","unstructured":"Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9641):807\u201316.","journal-title":"Lancet"},{"issue":"8","key":"253_CR6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/sj.bjp.0707673","volume":"153","author":"G Heusch","year":"2008","unstructured":"Heusch G. Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents. Br J Pharmacol. 2008;153(8):1589\u2013601.","journal-title":"Br J Pharmacol"},{"issue":"24","key":"253_CR7","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2010.09.014","volume":"56","author":"F Custodis","year":"2010","unstructured":"Custodis F, Schirmer SH, Baumh\u00e4kel M, et al. Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol. 2010;56(24):1973\u201383.","journal-title":"J Am Coll Cardiol"},{"key":"253_CR8","unstructured":"Itamar Medical User Manual, Software version 3.2.4. Available online. http:\/\/www.itamar-medical.com\/images\/Endo_PAT%20user%20manual%20for%203%202%204.pdf . Accessed 15 Jan 2012."},{"key":"253_CR9","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1161\/CIRCULATIONAHA.107.748574","volume":"117","author":"NM Hamburg","year":"2008","unstructured":"Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham heart study. Circulation. 2008;117:2467\u201374.","journal-title":"Circulation"},{"issue":"11","key":"253_CR10","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.jacc.2004.08.062","volume":"44","author":"PO Bonetti","year":"2004","unstructured":"Bonetti PO, Pumper GM, Higano ST, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137\u201341.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"253_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.numecd.2010.04.008","volume":"22","author":"R Ferr\u00e9","year":"2010","unstructured":"Ferr\u00e9 R, Plana N, Merino J, et al. Effects of therapeutic lifestyle changes on peripheral artery tonometry in patients with abdominal obesity. Nutr Metab Cardiovasc Dis. 2010;22(2):95\u2013105. doi: 10.1016\/j.numecd.2010.04.008 .","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"16","key":"253_CR12","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jacc.2009.10.073","volume":"55","author":"BQ Lian","year":"2010","unstructured":"Lian BQ, Keaney JF Jr. Predicting ischemic heart disease in women: the value of endothelial function. J Am Coll Cardiol. 2010;55(16):1688\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"253_CR13","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehq010","volume":"31","author":"R Rubinshtein","year":"2010","unstructured":"Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by noninvasive peripheral arterial tonometry predicts late cardiovascular adverse events. EHJ. 2010;31(9):1142\u20138.","journal-title":"EHJ"},{"key":"253_CR14","first-page":"904141","volume":"2012","author":"M Moerland","year":"2012","unstructured":"Moerland M, Kales AJ, Schrier L, et al. Evaluation of the EndoPAT as a tool to assess endothelial fuction. Int J Vasc Med. 2012;2012:904141.","journal-title":"Int J Vasc Med."},{"issue":"5","key":"253_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MCA.0000000000000094","volume":"25","author":"JS Woo","year":"2014","unstructured":"Woo JS, Jang WS, Kim HS, et al. Comparison of peripheral arterial tonometry and flow-mediated vasodilation for assessment of the severity and complexity of coronary artery disease. Coron Artery Dis. 2014;25(5):421\u20136.","journal-title":"Coron Artery Dis."},{"key":"253_CR16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5551\/jat.18986","volume":"21","author":"A Suessenbacher","year":"2014","unstructured":"Suessenbacher A, Dorler J, Wanitschek M, et al. Prognostic value of peripheral arterial tonometry in patients with coronary artery disease and a high cardiovascular risk profile. J Atheroscler Thromb. 2014;21:230\u20138.","journal-title":"J Atheroscler Thromb."},{"key":"253_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1476-7120-12-5","volume":"12","author":"N Jochmann","year":"2014","unstructured":"Jochmann N, Schr\u00f6ter F, Knebel F, et al. Effect of ivabradine-induced heart rate reduction on flow-mediated dilatation measured with high-sensitivity ultrasound in patients with stable coronary heart disease. Cardiovasc Ultrasound. 2014;12:5.","journal-title":"Cardiovasc Ultrasound"},{"issue":"24","key":"253_CR18","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1136\/heartjnl-2012-302795","volume":"98","author":"R Nerla","year":"2012","unstructured":"Nerla R, Di Franco A, Milo M, et al. Differential effects of heart rate reduction by atenolol or ivabradine on peripheral endothelial function in type 2 diabetic patients. Heart. 2012;98(24):1812\u20136.","journal-title":"Heart"},{"issue":"1","key":"253_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.amjcard.2013.02.045","volume":"112","author":"A Villano","year":"2013","unstructured":"Villano A, Di Franco A, Nerla R, et al. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris. Am J Cardiol. 2013;112(1):8\u201313.","journal-title":"Am J Cardiol"},{"issue":"1","key":"253_CR20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2010.11.035","volume":"215","author":"EI Skalidis","year":"2011","unstructured":"Skalidis EI, Hamilos MI, Chlouverakis G, Zacharis EA, Vardas PE. Ivabradine improves coronary flow reserve in patients with stable coronary artery disease. Atherosclerosis. 2011;215(1):160\u20135.","journal-title":"Atherosclerosis."},{"issue":"2","key":"253_CR21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/heartjnl-2013-304880","volume":"100","author":"S Gloekler","year":"2014","unstructured":"Gloekler S, Traupe T, Stoller M, Schild D, Steck H, Khattab A, Vogel R, Seiler C. The effect of heart rate reduction by ivabradine on collateral function in patients with chronic stable coronary artery disease. Heart. 2014;100(2):160\u20136.","journal-title":"Heart"},{"issue":"21","key":"253_CR22","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2013.07.027","volume":"62","author":"JC Reil","year":"2013","unstructured":"Reil JC, Tardif JC, Ford I, Lloyd SM, O\u2019Meara E, Komajda M, Borer JS, Tavazzi L, Swedberg K, B\u00f6hm M. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. J Am Coll Cardiol. 2013;62(21):1977\u201385.","journal-title":"J Am Coll Cardiol."},{"issue":"36","key":"253_CR23","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/ehs218","volume":"34","author":"JC Reil","year":"2013","unstructured":"Reil JC, Hohl M, Reil GH, Granzier HL, Kratz MT, Kazakov A, Fries P, M\u00fcller A, Lenski M, Custodis F, Gr\u00e4ber S, Fr\u00f6hlig G, Steendijk P, Neuberger HR, B\u00f6hm M. Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J. 2013;34(36):2839\u201349.","journal-title":"Eur Heart J"},{"key":"253_CR24","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000072696","volume":"40","author":"P Albaladejo","year":"2003","unstructured":"Albaladejo P, Carusi A, Apartian A, Lacolley P, Safar ME. BenetosA. Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vasc Res. 2003;40:320\u20138.","journal-title":"J Vasc Res"},{"key":"253_CR25","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1097\/00004872-200409000-00018","volume":"22","author":"P Albaladejo","year":"2004","unstructured":"Albaladejo P, Challande P, Kakou A, et al. Selective reduction of heart rate by ivabradine: effect on the visco-elastic arterial properties in rats. J Hypertens. 2004;22:1739\u201345.","journal-title":"J Hypertens"},{"issue":"2","key":"253_CR26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2011.06.098","volume":"151","author":"M Volterrani","year":"2011","unstructured":"Volterrani M, Cice G, Caminiti G, et al. Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). Int J Cardiol. 2011;151(2):218\u201324.","journal-title":"Int J Cardiol"},{"issue":"18","key":"253_CR27","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehn337","volume":"29","author":"G Heusch","year":"2008","unstructured":"Heusch G, Skyschally A, Gres P, et al. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Eur Heart J. 2008;29(18):2265\u201375.","journal-title":"Eur Heart J"},{"issue":"4","key":"253_CR28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bjp.2008.116","volume":"154","author":"A Drouin","year":"2008","unstructured":"Drouin A, Gendron ME, Thorin E, et al. Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Br J Pharmacol. 2008;154(4):749\u201357.","journal-title":"Br J Pharmacol"},{"issue":"18","key":"253_CR29","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1161\/CIRCULATIONAHA.107.746537","volume":"117","author":"F Custodis","year":"2008","unstructured":"Custodis F, Baumh\u00e4kel M, Schlimmer N, et al. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2008;117(18):2377\u201387.","journal-title":"Circulation"},{"issue":"10","key":"253_CR30","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/eurheartj\/ehr255","volume":"33","author":"SH Schirmer","year":"2012","unstructured":"Schirmer SH, Baumhakel M, Custodis F, et al. Heart-rate reduction by If-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis. Eur Heart J. 2012;33(10):1223\u201331.","journal-title":"Eur Heart J"},{"key":"253_CR31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1074248411405383","volume":"16","author":"G Heusch","year":"2011","unstructured":"Heusch G, Skyschally A, Schulz R. Cardioprotection by ivabradine through heart rate reduction and beyond. J Cardiovasc Pharmacol Ther. 2011;16:281\u20134.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"253_CR32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.2011.05960.x","volume":"1222","author":"E Canet","year":"2011","unstructured":"Canet E, Lerebours G, Vilaine JP. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine. Ann N Y Acad Sci. 2011;1222:90\u20139.","journal-title":"Ann N Y Acad Sci"},{"issue":"suppl H","key":"253_CR33","doi-asserted-by":"crossref","first-page":"H16","DOI":"10.1093\/eurheartj\/sui048","volume":"7","author":"R Ferrari","year":"2005","unstructured":"Ferrari R, Campo G, Gardini E, et al. Specific and selective If inhibition: expected clinical benefits from pure heart rate reduction in coronary patients. Eur Heart J Suppl. 2005;7(suppl H):H16\u201321.","journal-title":"Eur Heart J Suppl."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-015-0253-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-015-0253-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-015-0253-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:56:08Z","timestamp":1559447768000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-015-0253-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1007\/s12325-015-0253-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}